Recreating key features of the antibody factory in a dish
FDA Orphan Drug Designation and Rare Pediatric Disease Designation for sarcoma drug
Confidence boost for AI virtual cells for novel target discovery
Anti-fibrotic drug could be repurposed to control cell communication
Anbio Biotechnology develops Chikungunya rapid test
AMI Pharm advances fat-reduction injectable drug to phase 3
AI+CRISPR=Precise gene editing
AXA signs agreement with Hainan Boao Lecheng Administration
ProBio launches AAV manufacturing service
Altasciences and VoxCell BioInnovation to collaborate on preclinical drug development
KAIST develops AI that automatically designs optimal drug candidates for cancer-targeting mutations
MetaVia collaborating with Syntekabio to boost drug options